NCT01981135

Brief Summary

Purpose: The purpose of this protocol is to understand how individuals respond to the air pollutant ozone at elevated temperatures. Ultimately, this will help us understand what the risks from poor air quality are during a heat wave. Participants: We will recruit up to 30 healthy adults, 18-55 years old, to participate in this study. Procedures (methods): Subjects will be exposed to clean air and to 0.3 ppm of ozone for 2 hours with intermittent exercise in a controlled environment chamber. For each exposure the temperature in the chamber will be between 31-34oC (88-93 oF). Because the aim of the study is to mimic high exposure during a heat wave, we will perform exposures only on days when mean ambient temperatures was less than 24 oC in Chapel Hill on the previous day. Primary endpoints will include spirometry and Heart Rate Variability monitoring. Secondary endpoints will include analysis of blood clotting/coagulation factors, and analysis of soluble factors present in plasma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

October 22, 2013

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 11, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

February 10, 2015

Status Verified

February 1, 2015

Enrollment Period

2.5 years

First QC Date

October 22, 2013

Last Update Submit

February 9, 2015

Conditions

Keywords

Controlled Human exposure studyAir PollutionTemperatureLung FunctionCardiovascular

Outcome Measures

Primary Outcomes (1)

  • Forced expired volume in the first second (FEV1)

    Forced expired volume in the first second (FEV1) is determined by spirometry performed on a dry seal spirometer interfaced to a computer.

    Pre exposure to 24hours post exposure

Secondary Outcomes (4)

  • Index of clotting/coagulation factor

    Pre exposure to 24hours post exposure

  • Index of inflammatory markers

    Pre exposure to 24hours post exposure

  • Forced Vital Capacity

    Pre exposure to 24hours post exposure

  • Changes in heart rate variability

    Pre exposure to 24hours post exposure

Study Arms (2)

Clean Air

SHAM COMPARATOR

Exposure to clean air will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus.

Other: Clean Air

Ozone

EXPERIMENTAL

Exposure to ozone will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus.

Other: Ozone

Interventions

Each subject will be exposed to clean air for 2 hours. The exposure atmosphere will be at a temperature between 31-34oC (88-93 oF) and approximately 40 + 10% RH. Subjects will exercise on a bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.

Clean Air
OzoneOTHER

Each subject will be exposed up to 0.3ppm ozone for 2 hours. The exposure atmosphere will be at a temperature between 31-34oC (88-93 oF) and approximately 40 + 10% RH. Subjects will exercise on a bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.

Also known as: O3
Ozone

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \. Pass a physical exam performed by study physicians during the screening visit under a separate protocol.
  • \. Normal lung function:
  • FVC \> 75 % of that predicted for gender, ethnicity, age and height.
  • FEV1 \> 75 % of that predicted for gender, ethnicity, age and height.
  • FEV1/FVC ratio \> 75 % of predicted values. 3. Oxygen saturation of \> 96 %. 4. Ability to tolerate intervals of moderate exercise.

You may not qualify if:

  • \. A history of chronic illnesses such as diabetes, rheumatological diseases, immunodeficiency state, known clinically significant cardiac disease (including myocardial infarction, congestive heart failure and angina), chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma and lung cancer.
  • \. Smoking history within 2 years of the study. 5. Untreated hypertension (≥ 150 systolic, ≥ 90 diastolic). 6. Skin diseases or sensitivity precluding the use of ECG electrodes. 7. Symptom score greater than 21 (out of a possible 40-see accompanying score sheet) for total symptom score. Only one score may be equal to 3.
  • \. Dementia. 9. Unspecified illness or condition which in the judgment of the investigator might increase the risk associated with inhalation challenge or exercise.
  • \. Subjects who do not understand or speak English. 11. Subjects who are unable to perform moderate exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U.S. EPA Human Studies Facility

Chapel Hill, North Carolina, 27514, United States

Location

MeSH Terms

Interventions

Environment, ControlledOzone

Intervention Hierarchy (Ancestors)

EnvironmentEnvironment and Public HealthOxygenGasesInorganic Chemicals

Study Officials

  • David Diaz-Sanchez, PhD

    U.S. Environmental Protection Agency

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Clinical Research Branch

Study Record Dates

First Submitted

October 22, 2013

First Posted

November 11, 2013

Study Start

September 1, 2011

Primary Completion

March 1, 2014

Study Completion

January 1, 2015

Last Updated

February 10, 2015

Record last verified: 2015-02

Locations